Literature DB >> 20572082

Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.

Ulrich Lotze1, Renate Egerer, Brigitte Glück, Roland Zell, Holger Sigusch, Christian Erhardt, Albert Heim, Reinhard Kandolf, Thomas Bock, Peter Wutzler, Hans-R Figulla.   

Abstract

While myocardial parvovirus B19 (B19V), aside from enteroviruses (EV) and adenoviruses (ADV), has recently been found often in patients with myocarditis and idiopathic dilated cardiomyopathy (IDC), the pathogenetic significance of B19V genomes in those patients has not yet been sufficiently elucidated. In the present study, left ventricular endomyocardial biopsies from 24 patients with left ventricular ejection fraction (LVEF) below 55% due to IDC, and tissue from the right atrial appendage of 10 control patients undergoing bypass surgery with normal LVEF (>55%) were investigated for B19V, ADV, and EV genomes by specific nested polymerase chain reaction (PCR), by real time PCR or by reverse-transcription PCR, respectively. The myocardial tissue samples from the 10 controls were analyzed each in three different virological laboratories for B19V. In the IDC group, the frequency of the myocardial virus genomes found in 54% (13/24) of the patients was as follows: B19V: 50% (12/24), EV: 8% (2/24), including one patient with B19V and EV, and ADV: 0% (0/24). For comparison, the prevalence of B19V genomes was between 30% and 60% in the control group as detected in three different laboratories, but all these control subjects were EV- and ADV-negative. The number of B19V gene copies, however, was very low and similar both in the IDC and control group. In the majority of patients myocardial B19V persistence was associated with a low virus load irrespective of the underlying heart disease so that it may be of no importance in the pathogenesis of IDC. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20572082     DOI: 10.1002/jmv.21821

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  A high frequency of viral agents yet absence of Borrelia burgdorferi is seen within the myocardium of subjects with normal left ventricular systolic function: an electron microscopy study.

Authors:  Petr Kuchynka; Tomas Palecek; Tomas Grus; Jana Schramlova; Daniel Krsek; Ivana Vitkova; Vilem Rohn; Jaroslav Lindner; Eleanor Wicks; Eduard Nemecek; Gabriela Dostalova; Jana Podzimkova; Ales Linhart
Journal:  Folia Microbiol (Praha)       Date:  2015-07-24       Impact factor: 2.099

2.  Molecular Mechanisms behind Persistent Presence of Parvovirus B19 in Human Dilated Myocardium.

Authors:  Daiva Bironaitė; Ieva Kažukauskienė; Julius Bogomolovas; Dainius Daunoravičius; Artūras Jakubauskas; Dalius Vitkus; Edvardas Žurauskas; Kęstutis Ručinskas; Siegfried Labeit; Virginija Grabauskiene
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

Review 4.  The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).

Authors:  Kory J Lavine; Alexander R Pinto; Slava Epelman; Benjamin J Kopecky; Xavier Clemente-Casares; James Godwin; Nadia Rosenthal; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

Review 5.  How can we cure a heart "in flame"? A translational view on inflammation in heart failure.

Authors:  Ulrich Hofmann; Stefan Frantz
Journal:  Basic Res Cardiol       Date:  2013-06-06       Impact factor: 17.165

6.  Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).

Authors:  Fabiana Corcioli; Krystyna Zakrzewska; Rosa Fanci; Vincenzo De Giorgi; Massimo Innocenti; Matteo Rotellini; Simonetta Di Lollo; Alberta Azzi
Journal:  Virol J       Date:  2010-10-15       Impact factor: 4.099

Review 7.  Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy.

Authors:  Sophie Van Linthout; Carsten Tschöpe
Journal:  Curr Opin Cardiol       Date:  2018-05       Impact factor: 2.161

8.  Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity.

Authors:  Sophie Van Linthout; Ahmed Elsanhoury; Oliver Klein; Marzena Sosnowski; Kapka Miteva; Dirk Lassner; Mohamed Abou-El-Enein; Burkert Pieske; Uwe Kühl; Carsten Tschöpe
Journal:  ESC Heart Fail       Date:  2018-08-11

9.  The Impact of Specific Viruses on Clinical Outcome in Children Presenting with Acute Heart Failure.

Authors:  Maria Giulia Gagliardi; Alessandra Fierabracci; Mara Pilati; Marcello Chinali; Carlo Bassano; Francesca Saura; Isabella Giovannoni; Paola Francalanci
Journal:  Int J Mol Sci       Date:  2016-04-01       Impact factor: 5.923

10.  Viral genome changes and the impact of viral genome persistence in myocardium of patients with inflammatory cardiomyopathy.

Authors:  Dalibor Mlejnek; Jan Krejci; Petr Hude; Eva Ozabalova; Vita Zampachova; Radka Stepanova; Iva Svobodová; Tomas Freiberger; Eva Nemcova; Lenka Spinarova
Journal:  Arch Med Sci       Date:  2018-10-23       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.